Background: Normal pregnancy is a procoagulant state. In preeclampsia, this process of coagulation is exaggerated and will lead to further effects on the mother, placenta and fetus. The purpose of this study is to find out the changes that occur in the coagulation indices in pregnancy induced hypertension as compared to that in normal pregnancy which will help in the better management of patients with pregnancy induced Hypertension.Methods: This was a cross sectional study in 116 patients with normotensive and patients with hypertensive disorders in pregnancy conducted in a tertiary medical facility. Coagulation parameters like platelet count, prothrombin time, activated partial thromboplastin time, bleeding time and clotting time were eval...
Background: The thrombocytopenia in preeclampsia is mild to moderate, but severe thrombocytopenia ca...
Preeclampsia (PE) is an obstetric disorder with high morbidity and mortality rates but without clear...
Background: Pre-eclampsia is a complex disease process originating at the maternal- fetal interface ...
Background: Hypertensive disorders of pregnancy affect about 10% of all pregnant women around the wo...
Background: Pregnancy induced hypertension is a multisystem disorder and is characterized by changes...
AIM OF THE STUDY: To study coagulation profile changes in pregnancy induced hypertension. OBJECT...
Background: Hypertensive disorders of pregnancy is reported to cause about 60-80% of maternal deaths...
Background: Hypertensive disorders of pregnancy (HDP) represent a group of conditions associated wit...
BACKGROUND: PE (preeclampsia) is defined as new-onset hypertension and new onset proteinuria occurr...
Pregnancy induced hypertension (PIH) is one of the most common causes of both maternal and neonatal ...
Background: Preeclampsia is a dangerous complication which occurs potentially in pregnancy and is ch...
Background: Preeclampsia is an idiopathic multisystem disorder. It is associated with alteration of ...
Background: Hypertension is common complication of pregnancy and contributes significantly to matern...
Normal pregnancy is a hypercoagulable state with an increase in coagulation factor levels and a decr...
Preeclampsia (PE) is an obstetric disorder with high morbidity and mortality rates but without clear...
Background: The thrombocytopenia in preeclampsia is mild to moderate, but severe thrombocytopenia ca...
Preeclampsia (PE) is an obstetric disorder with high morbidity and mortality rates but without clear...
Background: Pre-eclampsia is a complex disease process originating at the maternal- fetal interface ...
Background: Hypertensive disorders of pregnancy affect about 10% of all pregnant women around the wo...
Background: Pregnancy induced hypertension is a multisystem disorder and is characterized by changes...
AIM OF THE STUDY: To study coagulation profile changes in pregnancy induced hypertension. OBJECT...
Background: Hypertensive disorders of pregnancy is reported to cause about 60-80% of maternal deaths...
Background: Hypertensive disorders of pregnancy (HDP) represent a group of conditions associated wit...
BACKGROUND: PE (preeclampsia) is defined as new-onset hypertension and new onset proteinuria occurr...
Pregnancy induced hypertension (PIH) is one of the most common causes of both maternal and neonatal ...
Background: Preeclampsia is a dangerous complication which occurs potentially in pregnancy and is ch...
Background: Preeclampsia is an idiopathic multisystem disorder. It is associated with alteration of ...
Background: Hypertension is common complication of pregnancy and contributes significantly to matern...
Normal pregnancy is a hypercoagulable state with an increase in coagulation factor levels and a decr...
Preeclampsia (PE) is an obstetric disorder with high morbidity and mortality rates but without clear...
Background: The thrombocytopenia in preeclampsia is mild to moderate, but severe thrombocytopenia ca...
Preeclampsia (PE) is an obstetric disorder with high morbidity and mortality rates but without clear...
Background: Pre-eclampsia is a complex disease process originating at the maternal- fetal interface ...